← SynDRA
Tyrphostin AG 555
SynDRA canonical compound SYN0157270 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CDK2 |
|---|
| Mechanism of action | tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- tyrosine kinase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- AG-555
- RefChem:933697
- DTXCID101475827
- ag555
- MLS000069704
- Tyrphostin B46
- SMR000058519
- MFCD00209865
- Tyrphostin B-46
- SR-01000000219
- Tyrphostin AG555
- Tocris-0618
- Tyrphostin deriv. 46
- Tyrphostin AG-555?
- Opera_ID_732
- Lopac-T-4818
- Lopac0_001158
- MLS001076316
- SCHEMBL645290
- BDBM4303
- AG 555 (Tyrphostin B46)
- SCHEMBL29378814
- cid_5328770
- GLXC-07465
- HMS2230N06
- HMS3414I05
- HMS3678I05
- 2-Cyano-3-(3,4-dihydroxyphenyl)-N-(3-phenylpropyl)acrylamide
- EX-A1470
- IFA55034
- HSCI1_000030
- s6525
- AKOS016368124
- CCG-205232
- CS-7554
- LP01158
- SDCCGSBI-0051125.P002
- NCGC00016028-01
- NCGC00016028-02
Look up Tyrphostin AG 555 in the interactive SynDRA portal →